Skip to main content
SpringerLink
Log in

A phase II evaluation of fazarabine in high-grade gliomas: a Southwest Oncology Group study

  • Clinical Trial Report
  • Fazarabine, Gliomas
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fine HA, Dear KBG, Loeffler JS, Black PM, Canellos GP (1991) Meta-analysis of radiotherapy with and without adjuvant chemotherapy for malignant gliomas in adults. Proc Am Soc Clin Oncol 10: 125

    Google Scholar 

  2. Glazer RI, Knode MC (1984) 1-B-d-arabinosyl-5-azacytosine: cytocidal activity and effects on the synthesis and methylation of DNA in human colon carcinoma cells. Mol Pharmacol 26: 381–387

    Google Scholar 

  3. Heideman R, Balis F, Lester C, et al (1987) Preclinical pharmacology of arabinosyl-5-azacytidine (AAC). Proc Am Assoc Cancer Res 28: 4

    Google Scholar 

  4. Shapiro WR (1986) Therapy of adult malignant brain tumors: what have clinical trials taught us? Semin Oncol 13: 38–45

    Google Scholar 

  5. Townsend A, Leclerc JM, Dutschman G, et al (1985) Metabolism of 1-B-d-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4). Cancer Res 45: 3522–3528

    Google Scholar 

  6. Walker MD, Alexander E, Hunt WE, et al (1976) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a cooperative clinical trial. J Neurosurg 49: 333–343

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Oklahoma Health Science Center, P.O. Box 26901, 73190, Oklahoma City, Oklahoma, USA

    George B. Selby

  2. Southwest Oncology Group Statistical Center, Seattle, Washington, USA

    Christine Upchurch

  3. University of Utah Medical Center, Salt Lake City, Utah, USA

    Jeannette Townsend & Harmon J. Eyre

Authors
  1. George B. Selby
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christine Upchurch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeannette Townsend
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Harmon J. Eyre
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This investigation was supported in part by the following PHS Cooperative Agreement grants awarded by the National Cancer Institute, DHHS: CA-38926, CA-42777, CA-04919, CA-04920, CA-28862, CA-45807, CA-4 CA-52772, CA-58658, CA-58686, CA-46113, CA-20319, CA-52654, and CA-32102.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Selby, G.B., Upchurch, C., Townsend, J. et al. A phase II evaluation of fazarabine in high-grade gliomas: a Southwest Oncology Group study. Cancer Chemother. Pharmacol. 34, 179–180 (1994). https://doi.org/10.1007/BF00685938

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00685938

Keywords

Search

Navigation